Injectable on-demand treatments for children with hereditary angioedema (HAE) are often associated with anxiety, pain, treatment delays, and high…
Articles by Margarida Maia, PhD
People with hereditary angioedema (HAE) who learn to accept and manage their disease, rather than constantly fighting or fearing…
Biocryst Pharmaceuticals is once again partnering with Neopharmed Gentili — now, with an Irish affiliate of the Italian pharmaceutical…
A single dose of lonvoguran ziclumeran (lonvo-z) left more than 60% of patients with hereditary angioedema (HAE) free…
Using a daily extended-release tablet of deucrictibant — an oral small molecule being developed by Pharvaris — together…
On-demand treatment with Ekterly (sebetralstat), marketed by Kalvista Pharmaceuticals for hereditary angioedema (HAE), reduced anxiety associated with…
Deucrictibant, an experimental oral small molecule from Pharvaris, delivers…
Use of Dawnzera (donidalorsen) — approved in the U.S. as a preventive treatment for hereditary angioedema (HAE) in…
On-demand treatment with deucrictibant, an experimental oral small molecule in the pipeline at Pharvaris, provides rapid relief from…
For sudden attacks of hereditary angioedema (HAE), many patients prefer — and remain satisfied with — using Ekterly (sebetralstat)…